baber/WOPTO huggingface dataset:
Patent AU-759683-B2 (AU)
Title: A chromatography method and a column material useful in said method
Inventor: IRGUM KNUT
IPC: B01J20/26
Filed: 1999-11-09
Granted: 2003-04-17
Abstract: A novel sorbent suitable for use as a stationary phase in a chromatography column, the core of which consists of an organic polymer of synthetic or natural origin. Further, the carrier exhibits a plurality of covalently bonded non-aromatic zwitterionic groups on its surface. Additionally, the invention also relates to a method for purifying a particular biological macromolecule, such as a protein or a nucleic acid, by zwitterionic ion exchange chromatography as well as an ion exchange column suitable for use in the zwitterionic ion exchange chromatography.
Patent AU-776044-B2 (AU)
Title: Antimcrobial activity of the first cationic cluster of human lactoferrin
Inventor: BERKEL PATRICK HENDRIKUS CORNE
IPC: C12N1/06
Filed: 2000-11-10
Granted: 2004-08-26
Abstract: The present invention provides polypeptides related to human lactoferrin protein that have utility in a variety of therapeutic and prophylactic applications, including use as antimicrobial agents. The invention further provides pharmaceutical compositions containing these polypeptides and therapeutic methods using such compositions. Methods for detecting antimicrobial infections using the polypeptides are also provided.
Patent AU-703950-B2 (AU)
Title: Hydrophobic drug delivery systems
Inventor: RUDNIC EDWARD M
IPC: A61K9/50
Filed: 1995-03-15
Granted: 1999-04-01
Abstract: A pharmaceutical preparation including a drug incorporated into hydrophobic particles comprised of long chain carboxylic acid or ester thereof or long chain alcohol, wherein the particles are incorporated into a unit dosage form and are individually coated with an enteric coating and/or the unit dosage form includes an enteric protective material.
Patent AU-771039-B2 (AU)
Title: A combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
Inventor: ERION MARK D
IPC: A61K31/427
Filed: 1999-12-22
Granted: 2004-03-11
Abstract: Pharmaceutical compositions containing an FBPase inhibitor and an insulin sensitizer are provided as well as methods for treating diabetes and diseases responding to increased glycemic control, an improvement in insulin sensitivity, a reduction in insulin levels, or an enhancement of insulin secretion.
Patent AU-689568-B2 (AU)
Title: Display fixture system
Inventor: CONEN ELLA B
IPC: A47F5/08
Filed: 1995-03-31
Granted: 1998-04-02
Abstract: A display fixture system for holding and displaying merchandise for sale comprises: a) a first substantially flat display panel having a front face, two side edges, a top end and a bottom end; b) a pair of side walls integral with the first panel side edges and extending from the top end to the bottom end of the first display panel and each of the side walls extending perpendicularly and rearwardly of the first display panel from a respective side edge; c) a pair of strengthening strips provided in the first panel and which are proximate respective side walls, each of the strengthening strips projecting outwardly of the panel front face and being integral therewith. The strengthening strips each extending from the top to the bottom end of the display panel; d) devices for removably attaching to the first display panel front face a merchandise shelf hook or the like for holding and displaying the merchandise; and e) a device for holding the display panel system in an substantially upright position. The display panel provides a load bearing structural unit of exceptional strength yet readily manufactured and readily installed to provide a variety of display designs.
Patent AU-686357-B2 (AU)
Title: An absorbent article
Inventor: WIDLUND URBAN
IPC: A41B13/00
Filed: 1995-03-17
Granted: 1998-02-05
Abstract: An absorbent article having a front part (12), a rear part (14) and an intermediate crotch part (13), such as a diaper, an incontinence guard or like article. The article includes an absorbent body (1), a liquid-impermeable bottom sheet (7) joined to the absorbent body, and a top sheet (9) which is free from connection with the absorbent body over a large part of its surface and which lies proximal to the wearer's body when the article is worn, and which top sheet includes an opening (15) which extends from the rear article part into the crotch part, and elastic devices (24, 25) which are fastened to the top sheet in a stretched state and which when contracting from the stretched state cause the part of the top sheet that is not joined to the absorbent body to be distanced from the body. The top sheet (9) includes a further opening (16) which extends from the front part (12) into the crotch part (13). A piece (26) of flexible material extends transversely across the article between the absorbent body (1) and the top sheet (9) within that region of the top sheet that lies between the two openings (15, 16), this piece of flexible material being fastened to the absorbent body and to the top sheet.
Patent AU-669114-B2 (AU)
Title: Improved signal encode/decode system
Inventor: JOHNSON KEITH O
IPC: G06J1/00
Filed: 1992-05-28
Granted: 1996-05-30
Abstract: A method for converting and encoding an analog signal to a digital format and subsequently decoding and converting said digital format to recover the analog signal, comprising the steps of monitoring the physical characteristics of an analog waveform to be converted to a digital format, converting said analog waveform to said digital format, encoding within said digital formal control information indicative of the physical characteristics of said analog waveform, whereby said analog waveform can subsequently be more accurately reconstructed from said digital format, decoding from said digital format said control information indicative of certain specified physical characteristics of said analog waveform, converting said digital format signal to said analog waveform, and peak limiting and restoring, and introducing compatible signal reconstruction compensation, in accordance with said control information during said converting process, said information facilitating subsequent more accurate reconstruction of said analog waveform from said digital format.
Patent AU-735631-B2 (AU)
Title: Diazepino-indoles as phosphodiesterase IV inhibitors
Inventor: PASCAL YVES
IPC: C07D487/06
Filed: 1997-03-27
Granted: 2001-07-12
Abstract: Diazepino indoles of formula (I), their racemic and isomeric forms, and their salts are new. A = aryl or nitrogen heteroaryl (both optionally substituted by 1-3 of halo, lower alkyl, haloalkyl, lower alkoxy, cycloalkoxy, amino, lower alkoxy- or alkyl-carbonylamino); B = OR1, NR2R3, NR2aR3a, NHR2', or NHR2''; R1 = H or R4; R2' = C(NH)NH2; R2'' = R4; R2a, R3a = H or lower alkyl; NR2R3 = 5-7 membered saturated heterocycle optionally containing O, N, or S not attached directly to the first N; R4 = CH2COOH, CO(CH2)pCOOH, COA, COCH=CHCOOH, CO(CH2)nCH3, CO(CH2OCH2)pCH2OCH3, CO(CH2OCH2)pCOOH or (CH2)pNR5aR6a or (CH2)pNR5R6; NR5R6 = as NR2R3; R5a, R6a = as R2a, R3a; n = 0-18; and p = 2-4. Also claimed are intermediates of formula (II).
Patent AU-651249-B2 (AU)
Title: Method for the determination of sulfidoleukotrienes in tissues and biological fluids and its application in diagnosis of allergies and other inflammatory diseases
Inventor: WECK ALAIN LADISLAS DE
IPC: C07K16/24
Filed: 1992-09-25
Granted: 1994-07-14
Abstract: PCT No. PCT/EP92/02238 Sec. 371 Date Jun. 1, 1993 Sec. 102(e) Date Jun. 1, 1993 PCT Filed Sep. 25, 1992 PCT Pub. No. WO93/07493 PCT Pub. Date Apr. 15, 1993.The method for detecting the sulfidoleukotrienes sLT of the group LTC4, LTD4 and LTE4 by a single immunoenzymatic ELISA assay is based on the interaction between one or several monoclonal anti-sLT antibodies and a sLT conjugated to a revealing enzyme. A biological sample, wherein a content of sLT is assumed, is contacted with a monoclonal anti-sLT antibody bound to a carrier. After the sLTs present in the sample are bound to the said antibody, a conjugate of a sLT with a revealing enzyme is added to the charged carrier. Finally the amount of the conjugate bound to the carrier is evaluated, which amount is in an inverse correlation with the sLT bound to the carrier. The method is useful for in vitro-tests for the diagnosis of inflammatory diseases, as rheumatic diseases, immuno deficiencies, allergies or pseudo-allergies. With a priming of the biological samples with cytokines, e.g. with IL3, IL5 or GM-CSF as priming agents, the sensitivity of the method can be increased.
Patent AU-572130-B2 (AU)
Title: 4-phenylamino pyrimidines
Inventor: HUBELE ADOLF
IPC: C07D239/58
Filed: 1984-04-06
Granted: 1988-05-05
Abstract: The invention relates to novel N-(2-nitrophenyl)-4-aminopyrimidine derivatives of the general formula I    <IMAGE>  (I)  wherein R1 is NO2 or CF3, R2 is NO2 or CF3, R3 is hydrogen or halogen, R4 is hydrogen or the -C(O)R7 group, wherein R7 is C1-C4alkyl which is unsubstituted or substituted by halogen, C1-C3alkoxy or C1-C3alkylthio, R5 and R6 are each independently halogen, C1-C6alkoxy, C1-C6alkyl which is substituted by halogen or C1-C3alkoxy, C1-C6alkoxy which is substituted by halogen or C1-C3alkoxy, C1-C6alkylthio or C1-C6alkylthio which is substituted by halogen or C1-C3alkoxy, or are C3-C6cycloalkoxy, C3-C6cycloalkylthio, C3-C6alkenyloxy, C3-C6alkenylthio, C3-C6alkynyloxy, C1-C6alkylsulfoxyl, C1-C6-alkylsulfonyl, C1-C6alkylsulfonyloxy, C3-C6alkenylsulfoxyl, C3-C6alkenylsulfonyl, C3-C6cycloalkylsulfoxyl or C3-C6cycloalkylsulfonyl. The invention relates further to methods of preparing these compounds as well as to agrochemical compositions which contain them. Also described is a method of controlling phytopathogenic micro-organisms with the aid of the novel compounds.
Patent AU-660052-B2 (AU)
Title: Process for reducing frequency interlacing during acoustic or optical signal transmission and/or recording
Inventor: EDLER BERND
IPC: G10L19/032
Filed: 1992-10-06
Granted: 1995-06-08
Abstract: PCT No. PCT/DE92/00855 Sec. 371 Date Apr. 15, 1994 Sec. 102(e) Date Apr. 15, 1994 PCT Filed Oct. 6, 1992 PCT Pub. No. WO93/08482 PCT Pub. Date Apr. 29, 1993A method for reducing frequency crosstalk in the transmission of digitized audio signals. Signals from partial bands in which spectral components of specific frequencies occur as signal components and signals from partial bands in which spectral components occur as crosstalk components in the stop range, undergo a weighted summation. Following transmission, the partial band signals undergo an inverse operation to weighted summation. The method operates independently of the selected encoding process, and is consequently universally usable.
Patent AU-563050-B2 (AU)
Title: Synthesis of azetidin-3-ols
Inventor: ORR ALEXANDER FERGUSON
IPC: C07D205/04
Filed: 1984-05-02
Granted: 1987-06-25
Abstract: A process for preparing 1-substituted azetidin-3-ol derivatives of formula: 
<CHEM>
 or an acid halide thereof, in which R<1> is an aryl methyl group; and R<2> is a hydrogen atom or an alkyl, aryl or aralkyl group, which comprises
 (a) reacting an epoxy halide of formula: 
<CHEM>
 in which Hal is a halogen atom, with a primary amine of formula:
 R<1> - NH2 III
 (b) cyclising the resulting addition product of formula: 
<CHEM>
 in an aqueous medium to form the acid halide of the compound of formula I, and
 (c) when the free hydroxy compound of formula I is required, treating said acid halide with a base. 
<??>The compounds are intermediates e.g. for the preparation of azetidine-3-carboxylic acid derivatives which exhibit plant growth regulant properties.
Patent AU-673501-B2 (AU)
Title: Nonpeptidyl integrin inhibitors having specificity for the GPIIbIIIa receptor
Inventor: BLACKBURN BRENT
IPC: C07D223/16
Filed: 1992-10-15
Granted: 1996-11-14
Abstract: A benzazepine derivative that acts as a nonpeptidyl platelet aggregation inhibitor is provided. This inhibitor potently inhibits fibrinogen binding to the GPIIbIIIa receptor and is provided in therapeutic compositions for the treatment of diseases for which blocking platelet aggregation is indicated. These nonpeptidyl inhibitors are provided in combination with thrombolytics and anticoagulants.
Patent AU-581412-B2 (AU)
Title: Tobacco product
Inventor: SHAW ALEC STANELY WALTER
IPC: A23G3/00
Filed: 1984-09-11
Granted: 1989-02-23
Abstract: There is disclosed a nicotine containing lozenge prepared from a mixture of inert filler material, a binder and either pure nicotine or a nicotine containing substance by a technique not involving any application of heat. Cold compression in a conventional tablet making machine is preferred.
Patent AU-766800-B2 (AU)
Title: Methods and compositions for altering mucus secretion
Inventor: LI YUEHUA
IPC: C12N5/071
Filed: 2000-02-24
Granted: 2003-10-23
Abstract: A peptide that inhibits mucus secretion in subjects is described, for use in inhibiting mucus secretion by a mucus secreting cell. A pharmaceutical composition comprising a myristoylated polypeptide and a pharmaceutically acceptable carrier is also described.
Patent AU-687255-B2 (AU)
Title: Indole-2,3-dione-3-oxime derivatives, their preparation and use
Inventor: MOLDT PETER
IPC: A61P25/00
Filed: 1995-09-12
Granted: 1998-02-19
Abstract: PCT No. PCT/EP95/03593 Sec. 371 Date May 20, 1997 Sec. 102(e) Date May 20, 1997 PCT Filed Sep. 12, 1995 PCT Pub. No. WO96/08494 PCT Pub. Date Mar. 21, 1996The present patent application discloses compounds having the formula or a pharmaceutically acceptable salt thereof wherein R1, X and R5 have the meanings set further in the specification. A is a ring of five to seven atoms fused with the benzo ring at the positions marked a and b. The compounds are useful in the treatment of cerebrovascular disorders for example.
Patent AU-630100-B2 (AU)
Title: Alpha-adrenergic receptor antagonists
Inventor: LAFFERTY JOHN JOSEPH
IPC: C07F9/6561
Filed: 1989-05-31
Granted: 1992-10-22
Abstract: Alpha-adrenoceptor antagonists having the formula: <CHEM> which are useful to produce  alpha -adrenoceptor antagonism, pharmaceutical compositions including these antagonists, and methods of using these antagonists to produce  alpha -adrenoceptor antagonism in mammals.
Patent AU-727852-B2 (AU)
Title: An electronic intrusion detection system for monitored environments
Inventor: TRUCCHI LUCIANO
IPC: G08B29/18
Filed: 1997-07-30
Granted: 2001-01-04
Abstract: The invention relates to an electronic intrusion detection system for monitoring environments, comprising at least one electronic sensor (1a, 1b, 1c) responsive to movements occurring in said environment and adapted to modify at least one characteristic of its electrical output in response to the presence of a moving body in said environment; means (10a, 10b, 10c) for generating an alarm signal (ALARM) when said modification meets a predetermined condition; and transducer means (20a, 20b, 20c) for continuously converting said modification of the output from said electric sensor (1a, 1b, 1c) into a signal that can be perceived by a human being. An alarm control unit (30) connected to said alarm generating means (10a, 10b, 10c) and transducer means (20a, 20b, 20c) includes means for forwarding the signals to the surveillance personnel through a telephone line (43).
Patent AU-581878-B2 (AU)
Title: Method of treating multiple sclerosis, rheumatoid arthritis or organ transplant rejection
Inventor: MURDOCK KEITH CHADWICK
IPC: A61K31/395
Filed: 1985-02-26
Granted: 1989-03-09
Abstract: This disclosure describes a method of inducing immunosuppression in mammals by the parenteral administration of certain 1,4 bis(substituted) anthraquinones.
Patent AU-768788-B2 (AU)
Title: Refrigeration evaporator
Inventor: REAGEN SCOTT
IPC: B23P15/26
Filed: 2000-03-06
Granted: 2004-01-08
Abstract: A method of making an evaporator and the resultant evaporator. The resultant evaporator comprises a continuous serpentine tube having an inlet and an outlet. The serpentine tube includes at least one column of parallel tube runs. Each tube run is defined by at least one reverse bend. The column of parallel tube runs has an overall length defined by the distance between the outermost tube runs. The evaporator further comprises a plurality of inner fins attached to the individual tubes. Each inner fin extends between two tube runs defined by opposite ends of a reverse bend. The inner fins have a length less than the overall length the column of tube runs.
Patent AU-774098-B2 (AU)
Title: Carnitine supplemented diet to prevent sudden death syndrome in broiler breeder type poultry
Inventor: TEETER ROBERT G
IPC: A61K31/105
Filed: 2000-03-23
Granted: 2004-06-17
Abstract: An effective amount of carnitine is administered to broiler breeder type poultry to prevent sudden death syndrome. In the preferred embodiment, a carnitine supplemented diet is fed to broiler breeder type chickens in a feed composition during a period of time preceding peak egg production. The feed composition preferably contains between 5 and 1000 ppm of carnitine.
Patent AU-666210-B2 (AU)
Title: Modem for communicating with enclosed electronic equipment
Inventor: PANTON STANLEY
IPC: G06F15/02
Filed: 1993-07-16
Granted: 1996-02-01
Abstract: A portable interface unit incorporates a modem for connecting a personal computer through a bidirectional communication link to enclosed process control equipment by passing radiation, preferably infra-red radiation, through a casing enclosing the unit. The computer has a bidirectional digital serial interface specified in accordance with an industry standard, and the modem has a complementary bidirectional digital serial interface, an optical modulator and an optical demodulator, and a power supply. The power supply can be a circuit to derive power from the serial interface of the personal computer, or from a battery. The portable interface unit provides a versatile bidirectional communications link which is particularly suitable for use in hazardous environments and with electronic equipment designed to be environmentally sealed or tamperproof, and permits general purpose computers to be used to program, diagnose, configure or interrogate such equipment.
Patent AU-671477-B2 (AU)
Title: Benzodiazepine derivatives
Inventor: JOSE LUIS CASTRO PINEIRO
IPC: C07D453/06
Filed: 1993-07-28
Granted: 1996-08-29
Abstract: PCT No. PCT/GB93/01599 Sec. 371 Date Jan. 26, 1995 Sec. 102(e) Date Jan. 26, 1995 PCT Filed Jul. 28, 1993 PCT Pub. No. WO94/03437 PCT Pub. Date Feb. 17, 1994Compounds of Formula (I), and salts and prodrugs thereof, wherein R1 represents H, optionally substituted C1-6alkyl or C3-7cycloalkyl; R2 is NHR12 or (CH2)sR13 where 5 is 0, 1 or 2; R3 represents C1-6alkyl, halo or NR6R7; R4 and R5 are H, C1-12alkyl optionally substituted by NR9R9' or an azacyclic or azabicyclic group, optionally substituted C4-9cycloalkyl, C4-9cycloalkyl C1-4alkyl, aryl, arylC1-6alkyl or azacyclic or azabicyclic groups, or R4 and R5 together form the residue of an optionally substituted azacyclic or azabicyclic ring system; x is 0, 1, 2 or 3; R12 is optionally substituted phenyl or pyridyl; R13 represents a group (A) wherein R14 is H or C1-6alkyl; R15 is H, C1-6alkyl, halo or NR6R7; and the dotted line is an optional covalent bond; are CCK and/or gastrin antagonists useful in therapy.    <IMAGE>  (I)   <IMAGE>  (A)
Patent AU-665669-B2 (AU)
Title: Use of tyloxapol as a nanoparticle stabilizer and dispersant
Inventor: JUNE SIEGFRIED K
IPC: A61K47/34
Filed: 1993-09-21
Granted: 1996-01-11
Abstract: A composition comprising nanoparticles having tyloxapol adsorbed on the surface thereof, preferably containing a diagnostic or therapeutic agent, and most preferably including a further surface modifier associated therewith is described. A method of making such nanoparticles and a method of diagnosis comprising administering to a mammal of a contrast effective amount of particles of nanoparticles having tyloxapol adsorbed on the surface thereof is also described.
Patent AU-661614-B2 (AU)
Title: Motion picture digital sound system and method with primary sound storage edit capability
Inventor: BEARD TERRY D
IPC: G11B27/10
Filed: 1993-08-02
Granted: 1995-07-27
Abstract: A digital sound system for motion picture films employs a digital time code on the film to trigger the transfer of sound data from a digital audio store to a FIFO memory. The digital audio data is read out from the FIFO memory and played back in the theater at a constant rate, with any jumps in the digital time code handled by making a corresponding jump within the digital audio store but not in the FIFO memory. Readout from the FIFO memory and clocking of the digital-to-analog converters (DACs) used for theater playback is synchronized to the AC mains that powers the theater projector, and thus allows for an uninterrupted audio playback even if time code entries on the film are obliterated. The FIFO memory need only have enough capacity to accommodate the maximum audio store access time, and can be quite small.
Patent AU-699263-B2 (AU)
Title: Process for the water-repellent impregnation of plaster
Inventor: GERHARDINGER DIETER
IPC: C04B24/42
Filed: 1996-04-18
Granted: 1998-11-26
Abstract: Water-repellent plaster compsn. contains 100 pts. wt. plaster of Paris, 0.05-50 pts. wt. alkali(ne earth) (hydr)oxide(s) and 0.05-20 pts. wt. organopolysiloxane with Si-bound OH and/or alkoxy gps. Also claimed is a method of giving a plaster a water-repellent finish. Suitable (hydr)oxides are CaO, MgO, Ca(OH2, Mg(OH)2 and NaOH. The organopolysiloxane comprises units of formula (I): Ra(OR')bSiO(4-a-b)/2 R = 1-18C (halo)hydrocarbyl; R' = 1-4C alkyl or H; l = 0, 1, 2 or 3 with an average value of 0.1-2.5; b = 0, 1,2,3 or 4 with an average value of 0.1-3.5.
Patent AU-529952-B2 (AU)
Title: Polymeric composition for scale prevention during sugar juce evaporation
Inventor: KELLER RENATE
IPC: C08L35/08
Filed: 1979-11-09
Granted: 1983-06-30
Abstract: Polymeric compositions useful for preventing formation of scale in apparatus used for evaporating sugar juices comprise a mixture of at least three polymers selected from polyacrolein or - methacrolein compounds, poly-acrylic or - methacrylic compounds, copolymers of the foregoing compounds, polyacrylamides and polymers of maleic anhydride alone or together with vinyl methyl ether, at least one of said polymers being present in an amount of at least 10% by weight and at least two of said polymers each being present in an amount of at least 5% by weight based on the total amount of said polymers.
Patent AU-619970-B2 (AU)
Title: Ballast circuits for discharge lamps
Inventor: VOS RAYMOND ARTHUR
IPC: H05B41/24
Filed: 1990-04-12
Granted: 1992-02-06
Abstract: A ballast circuit (1) for the operation of a discharge lamp includes a bridge rectifier (5). A capacitive energy storage device (C1) and a load circuit (9) are connected in series across the bridge rectifier (5). A charge circuit (12) provides charge to the capacitive energy storage (C1) from the load circuit (9) in a potential so as to add to the potential from the output of the bridge rectifier (5).